Gabriel Ocana-Santero is the cofounder and CEO of Exin Therapeutics.
Referenced in coverage
“Oxford PhD and CEO who claims he gave AI control of a custom motorized surgery rig to perform autonomous brain surgery on an epileptic mouse to reduce seizures.”